1. Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. J Pain. 2015; 16:769–780. PMID:
26028573.
Article
2. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain. 2006; 10:287–333. PMID:
16095934.
Article
3. Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012; 13:715–724. PMID:
22607834.
Article
4. Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. A classification of chronic pain for ICD-11. Pain. 2015; 156:1003–1007. PMID:
25844555.
Article
5. Totsch SK, Sorge RE. Immune system involvement in specific pain conditions. Mol Pain. 2017; 13:1744806917724559. PMID:
28741433.
Article
6. Ren K, Dubner R. Interactions between the immune and nervous systems in pain. Nat Med. 2010; 16:1267–1276. PMID:
20948535.
Article
7. Massart R, Dymov S, Millecamps M, Suderman M, Gregoire S, Koenigs K, et al. Overlapping signatures of chronic pain in the DNA methylation landscape of prefrontal cortex and peripheral T cells. Sci Rep. 2016; 6:19615. PMID:
26817950.
Article
8. Yoon JJ, Song JA, Park SY, Choi JI. Cytotoxic activity and subset population of peripheral blood natural killer cells in patients with chronic pain. Korean J Pain. 2018; 31:43–49.
Article
9. Brennan PC, Graham MA, Triano JJ, Hondras MA, Anderson RJ. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial. J Manipulative Physiol Ther. 1994; 17:219–227. PMID:
8046277.
10. Landis CA, Lentz MJ, Tsuji J, Buchwald D, Shaver JL. Pain, psychological variables, sleep quality, and natural killer cell activity in midlife women with and without fibromyalgia. Brain Behav Immun. 2004; 18:304–313. PMID:
15157947.
Article
11. Ritz BW, Alexander GM, Nogusa S, Perreault MJ, Peterlin BL, Grothusen JR, et al. Elevated blood levels of inflammatory monocytes (CD14+CD16+) in patients with complex regional pain syndrome. Clin Exp Immunol. 2011; 164:108–117. PMID:
21303362.
Article